Form 4: Royalty Pharma Director Fernandez Acquires Shares in Lieu of Retainer

Director Henry A. Fernandez acquired 1,342 Class A Ordinary Shares of Royalty Pharma plc in lieu of a quarterly retainer payment.

Summary

• Henry A. Fernandez, a director of Royalty Pharma plc, acquired 1,342 Class A Ordinary Shares on September 30, 2024.
• The shares were acquired at a price of $27.9249 each.
• This acquisition was made in lieu of a quarterly retainer payment of $37,500 under the Issuer's 2020 Independent Director Equity Incentive Plan.
• Following the transaction, Fernandez directly owns 54,002 Class A Ordinary Shares.
• Fernandez also indirectly owns 58,200 Class A Ordinary Shares through the Fernandez 2007 Children's Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as a director is increasing their stake in the company, which is generally seen as a good sign. The transaction is part of a pre-existing compensation plan.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future prospects.

Industry Context

Directors often receive equity as part of their compensation, aligning their interests with those of shareholders.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates